References
- Newman, D. J.; Cragg, G. M. Natural Products as Sources of New Drugs over the 30 Years from 1981 to 2010. J. Nat. Prod. 2012, 75, 311–335. DOI: https://doi.org/10.1021/np200906s.
- Lee, S. H.; Son, J. K.; Jeong, B. S.; Jeong, T. C.; Chang, H. W.; Lee, E. S.; Jahng, Y. Progress in the Studies on Rutaecarpine. Molecules 2008, 13, 272–300. DOI: https://doi.org/10.3390/molecules13020272.
- Son, J. K.; Chang, H. W.; Jahng, Y. Progress in Studies on Rutaecarpine. II.-Synthesis and Structure-Biological Activity Relationships. Molecules 2015, 20, 10800–10821. DOI: https://doi.org/10.3390/molecules200610800.
- Jiang, J.; Hu, C. Evodiamine: A Novel anti-Cancer Alkaloid from Evodia Rutaecarpa. Molecules 2009, 14, 1852–1859. DOI: https://doi.org/10.3390/molecules14051852.
- Hu, X.; Li, D.; Chu, C.; Li, X.; Wang, X.; Jia, Y.; Hua, H.; Xu, F. Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives. IJMS 2018, 19, 3403. DOI: https://doi.org/10.3390/ijms19113403.
- Deng, J.-D.; Lei, S.; Jiang, Y.; Zhang, H. H.; Hu, X.-L.; Wen, H.-X.; Tan, W.; Wang, Z. A Concise Synthesis and Biological Study of Evodiamine and Its Analogues. Chem. Commun. (Camb.) 2019, 55, 3089–3092. DOI: https://doi.org/10.1039/c9cc00434c.
- Ma, J.; Yang, R.; Guo, H.; Zhang, K.; Liu, J.; Feng, Y.; Zhou, J.; Jin, R.; Li, Z.; Guo, D.; et al. Antitumor Activity, Oil-Water Partition Coefficient, and Theoretical Calculation of 2 New Rutaecarpine Derivatives with Methoxy Groups. Nat. Prod. Commun. 2021, 16, 1–7.
- Dong, G.; Wang, S.; Miao, Z.; Yao, J.; Zhang, Y.; Guo, Z.; Zhang, W.; Sheng, C. New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure-Activity Relationship Analysis and Biological Evaluations. J. Med. Chem. 2012, 55, 7593–7613. DOI: https://doi.org/10.1021/jm300605m.
- Li, Z.-G.; Dong, G.-Q.; Wang, S.-Z.; Miao, Z.-Y.; Yao, J.-Z.; Zhang, W.-N.; Sheng, C.-Q. Optical Evodiamine Derivatives: Asymmetric Synthesis and Antitumor Activity. Chin. Chem. Lett. 2015, 26, 267–271. DOI: https://doi.org/10.1016/j.cclet.2014.11.011.
- Kim, S.; Lee, S. H.; Lee, E.-S.; Lee, C.-S.; Jahng, Y. New Topoisomerases Inhibitors: Synthesis of Rutaecarpine Derivatives and Their Inhibitory Activity against Topoisomerases. Arch. Pharm. Res. 2012, 35, 785–789. DOI: https://doi.org/10.1007/s12272-012-0504-1.
- Zhang, T.; Lai, Z.; Yuan, S.; Huang, Y.-Y.; Dong, G.; Sheng, C.; Ke, H.; Luo, H.-B. Discovery of Evodiamine Derivatives as Highly Selective PDE5 Inhibitors Targeting a Unique Allosteric Pocket. J. Med. Chem. 2020, 63, 9828–9837. DOI: https://doi.org/10.1021/acs.jmedchem.0c00983.
- Wang, B.; Mai, Y.-C.; Li, Y.; Hou, J.-Q.; Huang, S.-L.; Ou, T.-M.; Tan, J.-H.; An, L.-K.; Li, D.; Gu, L.-Q.; Huang, Z.-S. Synthesis and Evaluation of Novel Rutaecarpine Derivatives and Related Alkaloids Derivatives as Selective Acetylcholinesterase Inhibitors. Eur. J. Med. Chem. 2010, 45, 1415–1423. DOI: https://doi.org/10.1016/j.ejmech.2009.12.044.
- Dong, G.; Sheng, C.; Wang, S.; Miao, Z.; Yao, J.; Zhang, W. Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents. J. Med. Chem. 2010, 53, 7521–7531. DOI: https://doi.org/10.1021/jm100387d.
- Song, S.; Chen, Z.; Li, S.; Huang, Y.; Wan, Y.; Song, H. Design, Synthesis and Evaluation of N13-Substituted Evodiamine Derivatives against Human Cancer Cell Lines. Molecules 2013, 18, 15750–15768. DOI: https://doi.org/10.3390/molecules181215750.
- Liang, C.; Xia, J.; Song, H.; Zhou, Z.; Xue, Y.; Yao, Q. Synthesis, In Vitro and In Vivo Antitumor Activity and Docking Studies of New Evodiamine Derivatives. J. Chem. Pharm. Res. 2014, 6, 1161–1171.
- Hu, X.; Jiao, R.; Li, H.; Wang, X.; Lyu, H.; Gao, X.; Xu, F.; Li, Z.; Hua, H.; Li, D. Antiproliferative Hydrogen Sulfide Releasing Evodiamine Derivatives and Their Apoptosis Inducing Properties. Eur. J. Med. Chem. 2018, 151, 376–388. DOI: https://doi.org/10.1016/j.ejmech.2018.04.009.
- Hu, X.; Wang, Y.; Xue, J.; Han, T.; Jiao, R.; Li, Z.; Liu, W.; Xu, F.; Hua, H.; Li, D. Design and Synthesis of Novel Nitrogen Mustard-Evodiamine Hybrids with Selective Antiproliferative Activity. Bioorg. Med. Chem. Lett. 2017, 27, 4989–4993. DOI: https://doi.org/10.1016/j.bmcl.2017.10.014.
- Zhao, N.; Tian, K. T.; Cheng, K. G.; Han, T.; Hu, X.; Li, D. H.; Li, Z. L.; Hua, H. M. Antiproliferative Activity and Apoptosis Inducing Effects of Nitric Oxide Donating Derivatives of Evodiamine. Bioorg. Med. Chem. 2016, 24, 2971–2978. DOI: https://doi.org/10.1016/j.bmc.2016.05.001.
- Huang, G.; Drakopoulos, A.; Saedtler, M.; Zou, H.; Meinel, L.; Heilmann, J.; Decker, M. Cytotoxic Properties of the Alkaloid Rutaecarpine and Its Oligocyclic Derivatives and Chemical Modifications to Enhance Water-Solubility. Bioorg. Med. Chem. Lett. 2017, 27, 4937–4941. DOI: https://doi.org/10.1016/j.bmcl.2017.08.045.
- Michael, J. P. Indolizidine and Quinolizidine Alkaloids. Nat. Prod. Rep. 2007, 24, 191–222. DOI: https://doi.org/10.1039/b509525p.
- Michael, J. P. Indolizidine and Quinolizidine Alkaloids. Nat. Prod. Rep. 2008, 25, 139–165. DOI: https://doi.org/10.1039/b612166g.
- Sparatore, F.; Boido, V.; Preziosi, P.; Miele, E.; De Natale, G. Sintesi e Proprieta Farmacodinamiche di Alcuni Derivati Lupinanici. Farmaco Ed. Sci. 1969, 24, 587–621.
- Bondarenko, S. P.; Frasinyuk, M. S.; Galaev, A. I.; Vinogradova, V. I. New Flavonoid-Containing Derivatives of Lupinine. Chem. Nat. Compd. 2012, 48, 234–237. DOI: https://doi.org/10.1007/s10600-012-0212-6.
- Boido, A.; Vazzana, I.; Sparatore, F.; Cenicola, M. L.; Donnoli, D.; Marmo, E. Preparation and Pharmacological Activity of Some 1-Lupinylbenzimidazoles and 1-Lupinylbenzotriazoles. Farmaco 1991, 46, 775–788.
- Vazzana, I.; Budriesi, R.; Terranova, E.; Ioan, P.; Ugenti, M. P.; Tasso, B.; Chiarini, A.; Sparatore, F. Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents. J. Med. Chem. 2007, 50, 334–343. DOI: https://doi.org/10.1021/jm060878m.
- Tasso, B.; Budriesi, R.; Vazzana, I.; Ioan, P.; Micucci, M.; Novelli, F.; Tonelli, M.; Sparatore, A.; Chiarini, A.; Sparatore, F. Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents: 2. Further Investigation. J. Med. Chem. 2010, 53, 4668–4677. DOI: https://doi.org/10.1021/jm100298d.
- Sparatore, A.; Basilico, N.; Parapini, S.; Romeo, S.; Novelli, F.; Sparatore, F.; Taramelli, D. 4-Aminoquinoline Quinolizidinyl- and Quinolizidinylalkyl-Derivatives with Antimalarial Activity. Bioorg. Med. Chem. 2005, 13, 5338–5345. DOI: https://doi.org/10.1016/j.bmc.2005.06.047.
- Casagrande, M.; Basilico, N.; Parapini, S.; Romeo, S.; Taramelli, D.; Sparatore, A. Novel Amodiaquine Congeners as Potent Antimalarial Agents. Bioorg. Med. Chem. 2008, 16, 6813–6823. DOI: https://doi.org/10.1016/j.bmc.2008.05.068.
- Tasso, B.; Novelli, F.; Tonelli, M.; Barteselli, A.; Basilico, N.; Parapini, S.; Taramelli, D.; Sparatore, A.; Sparatore, F. Synthesis and Antiplasmodial Activity of Novel Chloroquine Analogues with Bulky Basic Side Chains. ChemMedChem. 2015, 10, 1570–1583. DOI: https://doi.org/10.1002/cmdc.201500195.
- Tasso, B.; Catto, M.; Nicolotti, O.; Novelli, F.; Tonelli, M.; Giangreco, I.; Pisani, L.; Sparatore, A.; Boido, V.; Carotti, A.; Sparatore, F. Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Potent Inhibitors of Acetyl- and Butyrylcholinesterase with Potential in Alzheimer's Disease. Eur. J. Med. Chem. 2011, 46, 2170–2184. DOI: https://doi.org/10.1016/j.ejmech.2011.02.071.
- Tonelli, M.; Catto, M.; Tasso, B.; Novelli, F.; Canu, C.; Iusco, G.; Pisani, L.; De Stradis, A.; Denora, N.; Sparatore, A.; et al. Multitarget Therapeutic Leads for Alzheimer's Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation. ChemMedChem 2015, 10, 1040–1053. DOI: https://doi.org/10.1002/cmdc.201500104.
- Nepali, K.; Sharma, S.; Sharma, M.; Bedi, P. M. S.; Dhar, K. L. Rational Approaches, Design Strategies, Structure Activity Relationship and Mechanistic Insights for Anticancer Hybrids. Eur. J. Med. Chem. 2014, 77, 422–487. DOI: https://doi.org/10.1016/j.ejmech.2014.03.018.
- Fortin, S.; Berube, G. Advances in the Development of Hybrid Anticancer Drugs. Exp. Opin. Drug Discov. 2013, 8, 1547–1577.
- Liu, R.; Chu, X.; Sun, A.; Kong, L. Preparative Isolation and Purification of Alkaloids from the Chinese Medicinal Herb Evodia rutaecarpa (Juss.) Benth by High-Speed Counter-Current Chromatography. J. Chromatogr. A. 2005, 1074, 139–144. DOI: https://doi.org/10.1016/j.chroma.2005.03.099.
- Noskova, V.; Dzubak, P.; Kuzmina, G.; et al. In Vitro Chemoresistance Profile and Expression/Function of MDR Associated Proteins in Resistant Cell Lines Derived from CCRF-CEM, K562, A549 and MDA MB 231 Parental Cells. Neoplasma 2002, 49, 418–425.
- Borkova, L.; Gurska, S.; Dzubak, P.; Burianova, R.; Hajduch, M.; Sarek, J.; Popa, I.; Urban, M. Lupane and 18α-Oleanane Derivatives Substituted in the Position 2, Their Cytotoxicity and Influence on Cancer Cells. Eur. J. Med. Chem. 2016, 121, 120–131. DOI: https://doi.org/10.1016/j.ejmech.2016.05.029.